SlideShare a Scribd company logo
1 of 92
• Immediate Past Chairperson ICOG –Indian College of
OB/GY
• National Corresponding Editor-Journal of OB/GY of
India JOGI
• National Corresponding Secretary-AMWI Association
of Medical Women, India
• President –ISOPARB Vidarbha Chapter 2019-21
• Chairperson-IMS Education Committee 2021-23
• Chairperson-fertility enhancement Committee-
ISOPARB
• Member-SAFOG Education Committee
• President-Association of Medical Women, Nagpur
AMWN 2021-24
• Senior Vice President FOGSI 2012
• President Menopause Society, Nagpur 2016-18
• President Nagpur OB/GY Society 2005-06
Dr. Laxmi Shrikhande
MBBS; MD(OB/GY);
FICOG; FICMU; FICMCH
Medical Director-
Shrikhande Fertility Clinic
Nagpur, Maharashtra
 Nagpur Ratan Award @hands of
Union Minister Shri Nitinji
Gadkari
 Received Bharat excellence Award
for women’s health
 Received Mehroo Dara Hansotia
Best Committee Award for her
work as Chairperson HIV/AIDS
Committee, FOGSI 2007-2009
 Received appreciation letter from
Maharashtra Government for her
work in the field of SAVE THE
GIRL CHILD
 Delivered 22 orations and
450 guest lectures
 Publications- 42 National &
21 International
 Sensitized 2 lakh boys and
girls on adolescent health
issues
Awards
Positions
IVF Pregnancy -
Is it Different ?
Dr Laxmi Shrikhande
Consultant –Shrikhande Hospital & Research Centre
Nagpur
ART Pregnancy
Assisted reproductive technology (ART) now accounts for 1.6%
of all infants and 18.3% of all multiple-birth infants in the United
States.
 Although most of these pregnancies are uncomplicated, IVF is
associated with several adverse maternal and perinatal
outcomes.
Why are ART pregnancies at higher risk?
Maternal age
Pre-existing co-morbidities
Cause of sub-fertility itself
Drugs for ovarian stimulation
Previous surgeries
IVF procedures
Kabhi Khushi Kabhi Gam…..
ART can alleviate the burden of infertility on individuals
and families, but it can also present challenges -
high rates of multiple delivery,
preterm delivery, and
low birth-weight delivery
ART pregnancies – are they different?
Reported to be associated with higher risk of complications, which can
be-
Due to multifetal pregnancies
Regardless of multiple gestation
Obstetric complications
Increased risk of obstetric complication from ART appears to apply to
twin gestations as well as singletons.
When compared with the non-ART dichorionic twins, the ART
neonates had an increased risk of preterm birth (RR 1.13, 95% CI
1.00-1.29), very preterm birth (RR 1.39, 95% CI 1.07-1.82), LBW (RR
1.11, 95% CI 1.00-1.23), and congenital malformations (RR 1.26, 95%
CI 1.09-1.46).
Luke B, Gopal D, Cabral H, et al. Adverse pregnancy, birth, and infant outcomes in twins: Effects of maternal fertility status and infant
gender combinations The Massachusetts Outcomes Study of Assisted Reproductive Technology. Am J Obstet Gynecol 2017.
RISKS ????
 Mother
 Fetus
ART Pregnancy- Maternal Risks
Miscarriages or Ectopic
 15% in women < 35,
 25% in women >35 and < 40
 35% in women > 42.
Multiple pregnancy
 Abortion
 Gestational hypertension
 Placental abruption
 Placenta previa.
 rate of obstetrical interventions
 Induced labour
 Elective Caesarean delivery
Psychosocial impact
ART Pregnancy- Fetal Risks
Chromosomal
 De novo (mainly sex) chromosomal abnormalities in IVF-ICSI
babies for male-factor infertility
 Aneuploidy in pregnancies adapted for maternal age and
number of fetuses
Multiple births
 Prematurity
 Low birth weight
 Neonatal Morbidity & Mortality
The best way to protect the mother's
health and that of the baby regardless of
how the pregnancy occurred is good
Antenatal surveillance .
Why Antenatal surveillance ??
1.Triage mothers to High Risk & Low Risk
2.Screen the fetus for
Chromosomal errors
Structural Defects
Growth abnormalities
3.Predict and prevent maternal complications
4.Decide the time and mode of safe delivery
Is there a standard protocol?
NO
Antenatal care
Continue Progesterone Support
How long? Individualize for every patient profile.
Micronized progesterone vaginally is the drug of
choice.
Continue folic acid supplementation
Continue Thyroid medication if she is already on it
Continue prescribed medicines by ART consultant
Antenatal care
Routine Blood Tests
Additional blood tests for Monitoring -
Look for rising hCG titres
Case specific
Haemoglobinopathy screening
O H S S
“Abundance,
like want,
ruins many”.
~ Romanian Proverb ~
Patterns of OHSS
Early OHSS
generally presents 3–7 days after hCG administration
acute effect of ovulatory hCG, and it can occur in
patients who do not become pregnant.
Late OHSS
presenting 12–17 days after hCG.
late OHSS is induced by endogenous hCG from the
trophoblast of the implanting pregnancy.
Wheelan JG 3rd, Vlahos NF. Fertil Steril 2000; 73:883–896.
Management of OHSS
Principles
 Monitoring
 Supportive therapy
 Maintenance of intravascular volume
 Prevention/treatment of complication
 Counseling - Signs and symptoms of OHSS
Management of OHSS
 OUTPATIENT CARE
 Limit activity
 Weigh daily
 Monitor I/O
 Daily follow up
 Report if symptoms
worsen or
weight gain > 2lb/day
 INPATIENT CARE
 Monitor
 Vitals every 4 hours
 I/O
 Daily weight & AG
 Hematocrit,TC,DC,
 Serum electrolytes, RFT
 LFT,PT, APTT on admission
repeated if necessary
 ICU
 Renal faillure,
 ARDS,
 DIC
Mild to Moderate OHSS
Increased fluid intake.
Frequent physical exams and ultrasounds.
Daily weigh-ins and waist measurements to check for drastic
changes.
Measurements of how much urine you produce each day.
Blood tests to monitor for dehydration, electrolyte imbalance
and other problems.
Who are at risk for OHSS ?
Prevention is better than cure
Avoid HCG – Cancellation of cycle
Which Protocol ?
Antagonist Protocol
Agonist Trigger
Freeze all embryos
OHSS free clinic
First trimester
What would you advise / look for?
New shift
 Some very important complications that occur later in pregnancy can be
predicted in the first trimester itself.
 Inverted pyramid helps in dividing cases into high risk & low risk in the first
trimester
Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagn Ther 2011;29: 183–96.
USG @ 6-7 weeks
 Exact dating of pregnancy
 Ectopic pregnancy/ Heterotopic pregnancy
 Missed abortion
 Single /Multiple pregnancy
 If Multiple-Chorionicity
Miscarriage
Following ART the risk of miscarriage may seem a bit higher
than in spontaneous pregnancies, but
 this is thought to be due to earlier pregnancy detection on
the one hand,
 and to older maternal age on the other
Multiple Births
 The major complication of IVF is the risk of multiple
births
 This is directly related to the practice of transferring
multiple embryos at embryo transfer.
Can Multiple Births be prevented?
• Strict limits on the number of embryos that may be transferred have
been enacted in some countries (e.g. Britain, Belgium) to reduce the
risk of high-order multiples (triplets or more), but are not universally
followed or accepted.
• Spontaneous splitting of embryos in the womb after transfer can
occur, but this is rare and would lead to identical twins.
Vanishing Twin
 In IVF twins are more often conceived than born. Most vanish in due
course of time
 Still the true incidence of vanishing twins is difficult to assess.
 According to one data it was estimated that ∼30% of these twins will
ultimately result in singletons and <10% will end in a complete
abortion.
Monochorionic twins
 More complications because of shared placenta
 TTTS
 Single twin demise
 Mono amnionicity
 TRAP
 Conjoined twins
 When monochorionic twins were compared with dichorionic twin
pregnancies , the rate of fetal loss was significantly higher in the former.
Management of monochorionic twins
 Chorionicity established early
 USG surveillance starts at 16 weeks for
TTTS & growth discordance
 Scan every 2 weeks
 If uncomplicated,deliver at 36-37
weeks
TTTS
 Main feature is growth discordance
 If growth discordance >25% , intense
surveillance started
 NST twice weekly
 If non-reactive NST ,biophysical profile done
 Doppler studies is done to follow up growth
restriction
 Interventions when needed
Multiple pregnancy
AIM of ANC
 Prolongation of gestation age, increase fetal weight.
 Improve PNM and morbidity.
 Decrease incidence of maternal complications.
ANC
 Consultant-led team
 Embryo reduction in higher order multiple gestations
 Best after 11 weeks-10% risk of miscarriage
 Visits - Every two weeks.
 Iron and folic acid to avoid anemia.
 Assess cervical length and competency.
 Careful watch for complications
Multiple pregnancy
Maternal Risks-
 Hyperemesis gravidarum
 Abortion
 Hypertensive disease, 4x more common than singletons
 Gestational diabetes
 Preterm delivery
 Anaemia
 Hydramnios in 12%, primarily in monozygotic twins
 Reflux, abdominal discomfort, back pain, leg swelling,
 Bladder symptoms and Hemorrhoids
 APH (PP and Abruptio, as larger placental area and PET)
 Thromboembolic disease: appropriate prophylaxis and Rx
Fetal Risks-
• Perinatal Morbidity
• Perinatal mortality
• Preterm delivery
• Low birth weight.
Multiple pregnancy
Monitoring after Single twin demise / fetal reduction
 Baseline coagulation profile for mother
 Usually preterm labor starts
 Counsel regarding prognosis for second twin
 17% risk of neurological damage
 Early delivery not warranted as preterm
delivery may harm the surviving twin
 CS not needed
 Embryo reduction in higher order multiple gestations
 Best after 11 weeks
 10% risk of miscarriage
Embryo reduction
Embryo reduction
 The most common method is to inject potassium chlorideinto the
fetus's heart; the heart stops and the fetus dies as a result.
 Generally, the fetal material is reabsorbed into the woman's body.
 While the procedure generally reduces the over-all risk level for the
remaining fetus or fetuses.
IVF Multiple Births have Good Outcome
 However, despite the risks, some recent evidence suggests that twins
conceived by IVF actually have a 40% decreased outcome risk for
complications than spontaneous twin conceptions.
 Experts believe that this could be due to high level of prenatal
monitoring received from the moment of conception.
Are congenital anomalies increased in IVF pregnancies?
 Meta-analyses demonstrate associations between IVF/ICSI and congenital malformations,
although it remains unclear if this association is due to infertility, factors associated with
the procedure, or both.30-32 It is also difficult to distinguish the risk associated with IVF
alone versus IVF with ICSI.
 Therefore, we recommend a detailed obstetrical ultrasound examination (CPT
76811) be performed for pregnancies achieved with IVF and ICSI (GRADE 1B).33
30.Chen L, Yang T, Zheng Z, Yu H, Wang H, Qin J. Birth prevalence of congenital malformations in singleton pregnancies resulting from in vitro
fertilization/intracytoplasmic sperm injection worldwide: a systematic review and meta-analysis. Arch Gynecol Obstet 2018;297(5):1115-1130.
31.Hoorsan H, Mirmiran P, Chaichian S, Moradi Y, Hoorsan R, Jesmi F. Congenital Malformations in Infants of Mothers Undergoing Assisted Reproductive
Technologies: A Systematic Review and Meta-analysis Study. J Prev Med Public Health 2017;50(6):347-360.
32.Wen J, Jiang J, Ding C, et al. Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis. Fertil Steril
2012;97(6):1331-7.e1-4.
33.AIUM Practice Parameter for the Performance of Detailed Second- and Third-Trimester Diagnostic Obstetric Ultrasound Examinations. J Ultrasound Med
2019;38(12):3093-3100.
Are CHD risks increased in IVF pregnancies?
 Several studies report higher rates of total congenital heart disease (CHD) in the IVF/ICSI population
compared with naturally occurring pregnancies, while other studies report that the incidence of CHD
in IVF pregnancies without other risk factors is not significantly different from baseline population
rates.34 The cost-effectiveness of routine screening for CHD in pregnancies following IVF has also
been questioned.35,36
 We suggest fetal echocardiography be offered to patients with pregnancies achieved with IVF
and ICSI (GRADE 2C).37
34.Giorgione V, Parazzini F, Fesslova V, et al. Congenital heart defects in IVF/ICSI pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol
2018;51(1):33-42.
35.Bjorkman KR, Bjorkman SH, Ferdman DJ, Sfakianaki AK, Copel JA, Bahtiyar MO. Utility of routine screening fetal echocardiogram in pregnancies conceived by in vitro
fertilization. Fertility and Sterility 2021.
36.Chung EH, Lim SL, Havrilesky LJ, Steiner AZ, Dotters-Katz SK. Cost-effectiveness of prenatal screening methods for congenital heart defects in pregnancies conceived by
in-vitro fertilization. Ultrasound Obstet Gynecol 2021;57(6):979-986.
37.AIUM Practice Parameter for the Performance of Fetal Echocardiography. J Ultrasound Med 2020;39(1):E5-e16.
Antenatal care
Hyperemesis-challenge with so many medications
Discuss options for prenatal screening for
congenital structural abnormalities
Biochemical
Sonographic screening
Antenatal care-11-13 weeks
Self egg versus donor egg cycle
 Screening for the baby:
 Combined test –Double Marker
 USG – NT & Soft tissue Markers
 assessing normal fetal growth
 Vanishing twins
 Need for fetal reduction
 Cervical length
 P/S exam
 CVB/ NIPT
Prenatal diagnosis
 Nuchal translucency measurement with maternal age is the best
method for aneuploidy screening
 Advantage: fetus specific
 Structural anomaly scan for NTDs
 Combine NT scan with Uterine artery Doppler,
 Tricuspid flow and DV -95-97%
Screening for Trisomy 21 at 11- 14 weeks for
India
2-stage (contingency) screening proposed
RISK ESTIMATE BY ONLY USG N.T. AND OTHER MARKERS
Fetal NT
Nasal bone and
ductus venosus
tricuspid
regurgitation at 12
wks
Very high risk
Very low risk
CVS
Reassure
Borderline
risk
Further
screening
Free B hCG
PAPP-A
THIS WILL SAVE
TIME
MONEY
OPTIMUM USE OF OUR
SKILL
DOUBLE MARKER
TEST
Scan 20w NIPT
Antenatal care
 Screening for the pregnant woman:
 Gestational diabetes
 Pre-eclampsia and preterm labour
 Placenta Previa
 Asymptomatic bacteriuria
 Chlamydia.
Cervical length screening routine to prevent
preterm labour and for guideline for cx stitch
Asymptomatic singleton pregnancy a tvs cl <25 mm in second trimester
Screen at 11-13 weeks and then at 22-24 weeks
Recent evidence says cx stitch does not help and progesterone may be
the only treatment option here.
Routine mcdonald stitch practise should be individualised
ANC care @ 18-20 weeks
Self egg versus donor egg cycle
Quadruple Marker
Anomaly scan
Cervical length
P/S exam
NIPT/Amniocentesis
Fetal ECHO @ 22 weeks
PIH
 A cohort study of over 5 Lakh women was done to determine the risk
of preeclampsia in women undergoing ART, including IVF, compared
with women who had a natural conception.
 After adjusting for maternal age, interbirth interval, and presence of
new partner, women undergoing ART had a small increase in odds of
preeclampsia in their second and third pregnancies compared with
women who did not require ART (OR 1.3 for second pregnancy and
1.8 for third pregnancy) .
Tandberg A, Klungsøyr K, Romundstad LB, Skjærven R. Pre-eclampsia and assisted reproductive technologies:
consequences of advanced maternal age, interbirth intervals, new partner and smoking habits. BJOG 2015; 122:915.
PIH in OD cycle
• In a meta-analysis of 19 studies (mainly retrospective) that compared
the risk of preeclampsia and gestational hypertension in pregnancies
conceived via oocyte donation (OD), other ART, and natural
conception, pregnancies achieved with OD had more than double the
risk of preeclampsia when compared with other methods of ART and
a more than fourfold increased risk compared with natural
conception (OR 2.54, 95% CI 1.98-3.24 and OR 4.34, 95% CI 3.10-6.06,
respectively) .
Masoudian P, Nasr A, de Nanassy J, et al. Oocyte donation pregnancies and the risk of preeclampsia or
gestational hypertension: a systematic review and metaanalysis. Am J Obstet Gynecol 2016; 214:328.
In pregnancies achieved with IVF,does low-dose aspirin
prophylaxis reduce the risk of fetal & placental
complications?
 IVF and underlying infertility are associated with adverse perinatal outcomes, including
hypertensive disorders of pregnancy.47 The United States Preventative Services Task Force
states IVF is a moderate risk factor for preeclampsia and recommends low-dose aspirin if
an additional moderate risk factor is found.48
 We do not recommend low-dose aspirin in patients with an IVF pregnancy as the
sole indication for preeclampsia prophylaxis; however, if one or more additional risk
factors are present, low-dose aspirin is recommended (GRADE 1B).
47.Tandberg A, Klungsoyr K, Romundstad LB, Skjaerven R. Pre-eclampsia and assisted reproductive technologies: consequences of advanced
maternal age, interbirth intervals, new partner and smoking habits. BJOG 2015;122(7):915-22
48.Davidson KW, Barry MJ, Mangione CM, et al. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services
Task Force Recommendation Statement. Jama 2021;326(12):1186-1191.
PIH/PTB/LSCS in OD Cycle
 A different meta-analysis of 11 studies that compared oocyte
donation (OD) pregnancies with pregnancies resulting from
autologous oocyte IVF or ICSI reported that women with OD
pregnancies had a nearly fourfold increased risk of developing
preeclampsia or pregnancy-induced hypertension compared with
autologous IVF/ICSI pregnancies (OR 3.92, 95% CI 2.62-5.16).
 The increased risk was independent of maternal age.
 In secondary analysis, OD pregnancies were also associated with an
increased risk of preterm delivery and cesarean delivery.
Jeve YB, Potdar N, Opoku A, Khare M. Donor oocyte conception and pregnancy complications: a systematic
review and meta-analysis. BJOG 2016; 123:1471.
Is the prevalence of spontaneous preterm birth higher in IVF pregnancies?
 A meta-analysis of singleton pregnancies demonstrated that IVF is associated with higher odds of preterm
delivery, low birthweight, and very low birthweight compared with naturally occurring pregnancies.40
 Preterm birth has been recognized for several decades as the primary independent cause of increased rates of
several adverse neonatal outcomes, including neonatal encephalopathy and perinatal mortality, in IVF
pregnancies.
 Such risks are more than double in the presence of IVF twin gestations. Subfertility is also a major risk factor for
prematurity.41 Although there may be an increased risk for spontaneous preterm birth with IVF pregnancies, the
utility of serial cervical length measurement to screen for preterm birth risk is unknown when the sole indication
is IVF.
 Although visualization of the cervix at the 18 0/7 to 22 6/7 weeks of gestation anatomy assessment with
either a transabdominal or endovaginal approach is recommended, we do not recommend serial cervical
length assessment as a routine practice for IVF pregnancies (GRADE 1C).42,43
 In addition, progesterone supplementation initiated for IVF cycles is not indicated after 12 weeks of gestation if it
was solely initiated for IVF purposes without any other indication. Discontinuation of progesterone
supplementation initiated for the sole purpose of IVF is recommended by 12 weeks.
40.Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004;103(3):551-63.
41.Pinborg A, Wennerholm UB, Romundstad LB, et al. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-
analysis. Hum Reprod Update 2013;19(2):87-104.
42.Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234. Obstet Gynecol 2021;138(2):e65-e90.
43.McIntosh J, Feltovich H, Berghella V, Manuck T. The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention. Am J Obstet Gynecol
2016;215(3):B2-7.
Is the prevalence of fetal growth restriction higher in IVF pregnancies?
 An increased risk of small for gestational age (SGA) infants is documented for singleton
IVF pregnancies. Meta-analyses have described a higher risk of SGA babies in IVF/ICSI
pregnancies from fresh cycles compared with frozen cycles.41,44-46
 The optimal gestational ages for fetal growth scans and their frequency in the presence of
additional risk factors (eg, placental implantation anomalies or maternal age >40 years)
are presently unknown.
 We suggest an assessment of fetal growth in the third trimester for IVF pregnancies;
however, serial growth ultrasounds are not recommended for the sole indication of
IVF (GRADE 2B).
44.Maheshwari A, Pandey S, Shetty A, Hamilton M, Bhattacharya S. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of
frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril 2012;98(2):368-77.e1-9.
45.Sha T, Yin X, Cheng W, Massey IY. Pregnancy-related complications and perinatal outcomes resulting from transfer of cryopreserved versus fresh embryos
in vitro fertilization: a meta-analysis. Fertil Steril 2018;109(2):330-342.e9.
46.Wennerholm UB, Henningsen AK, Romundstad LB, et al. Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic cohort study from
the CoNARTaS group. Hum Reprod 2013;28(9):2545-53.
Third trimester
 Close monitoring for fetal growth
 Close monitoring for preterm labour
 Pay special attention to Placenta-praevia, adherent
Sun LM, Walker MC, Cao HL, et al. Assisted reproductive technology and placenta-mediated adverse pregnancy
outcomes. Obstet Gynecol 2009; 114:818.
Romundstad LB, Romundstad PR, Sunde A, et al. Increased risk of placenta previa in pregnancies following
IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother. Hum Reprod 2006; 21:2353.
Are placental anomalies increased in IVF pregnancies?
 IVF pregnancies are associated with higher risks for abnormal placental shape (bilobed placenta,
accessory placental lobes), placenta previa, marginal or velamentous cord insertion, and placenta
accreta spectrum compared with naturally occurring pregnancies.
 All of the above manifestations of placental implantation disorders appear related and can occur
together.
 Therefore, we recommend a careful examination of the placental location, placental shape,
and cord insertion site be performed at the time of the detailed fetal anatomy ultrasound,
including evaluation for vasa previa (GRADE 1B).
 Targeted screening via transvaginal sonogram should be considered in all IVF pregnancies with
velamentous cord insertion, succenturiate or bilobed placentas, or resolved placenta previa to rule
out vasa previa.38,39 Due to the ongoing risk of vasa previa in the setting of resolved placenta previa,
reassessment for vasa previa is warranted when reassessing placental location at 32 weeks of
gestation.
38.Sinkey RG, Odibo AO, Dashe JS. #37: Diagnosis and management of vasa previa. Am J Obstet Gynecol 2015;213(5):615-9.
39.Sullivan EA, Javid N, Duncombe G, et al. Vasa Previa Diagnosis, Clinical Practice, and Outcomes in Australia. Obstet Gynecol 2017;130(3):591-598.
Placenta Praevia
• In a meta-analysis of 15 cohort studies comparing ART-conceived with
naturally conceived dichorionic twins, women with ART dichorionic
twins had nearly three times the risk of placenta previa as women
with naturally conceived dichorionic twins (RR 2.99, 95% CI 1.5-5.9) .
Qin JB, Wang H, Sheng X, et al. Assisted reproductive technology and risk of adverse obstetric outcomes in dichorionic
twin pregnancies: a systematic review and meta-analysis. Fertil Steril 2016; 105:1180.
Antenatal corticosteroids
• A single course of corticosteroids is recommended for pregnant
women between 24 0/7 weeks and 33 6/7 weeks of gestation
who are at risk of preterm delivery within 7 days, including for
those with ruptured membranes and multiple gestations.
Antenatal corticosteroids
• It also may be considered for pregnant women starting at 23 0/7 weeks of
gestation who are at risk of preterm delivery within 7 days, based on a family’s
decision regarding resuscitation, irrespective of membrane rupture status and
regardless of fetal number.
Antenatal corticosteroids
• Administration of betamethasone may be considered in pregnant women
between 34 0/7 weeks and 36 6/7 weeks of gestation who are at risk of
preterm birth within 7 days, and who have not received a previous course of
antenatal corticosteroids.
Antenatal corticosteroids
24-34 weeks [Grade A recommendation]
More effective when delivered after 24 hours and upto 7 days after 2nd
dose [Grade A]
Repeated doses not needed
Consider rescue dose if initial dose before 26 weeks
Fetal Care
 Combined Screening,Fetal ECHO, LBW, IUGR…
 NT,soft tissue markers,double marker,
 dedicated anomaly scan, quadruple marker,
 3 D USG,
 serial USG,
 Doppler…
 Fetal Kick Count
Is the prevalence of stillbirth increased in IVF pregnancies?
 Pregnancies achieved with IVF have a two to three-fold increased risk of
stillbirth even after controlling for maternal age, parity, and multifetal
gestations.40,49-51
 Given the increased risk of stillbirth, we suggest weekly antenatal
fetal surveillance beginning by 36 0/7 weeks of gestation for
pregnancies achieved with IVF (GRADE 2C).52
49.Bay B, Boie S, Kesmodel US. Risk of stillbirth in low-risk singleton term pregnancies following fertility treatment: a national cohort study.
BJOG 2019;126(2):253-260.
50.Marino JL, Moore VM, Willson KJ, et al. Perinatal outcomes by mode of assisted conception and sub-fertility in an Australian data linkage
cohort. PLoS One 2014;9(1):e80398.
51.Wisborg K, Ingerslev HJ, Henriksen TB. IVF and stillbirth: a prospective follow-up study. Hum Reprod 2010;25(5):1312-6.
52.Indications for Outpatient Antenatal Fetal Surveillance: ACOG Committee Opinion, Number 828. Obstet Gynecol 2021;137(6):e177-e197.
Stillbirth
A national cohort study from Denmark of low-risk ART pregnancies
reported stillbirth rates of 0.1 percent following IVF and 0.3 percent
after ICSI .
 For low-risk patients, it is not known if the increased stillbirth risk is
related to the treatment or the underlying subfertility.
Bay B, Boie S, Kesmodel US. Risk of stillbirth in low-risk singleton term pregnancies following
fertility treatment: a national cohort study. BJOG 2019; 126:253.
The Various Methods of Antepartum Fetal Surveillance
1) Clinical assessment by uterine growth
2) Fetal movement count by the mother
3) Ultrasound for fetal growth
4) Non stress test and cardiotocography
5) Vibroacoustic stimulation test
6) Contraction stress test
7) Nipple stimulation test
8) Biophysical profile
9) Modified biophysical profile
10) Doppler studies
11) Fetal lung maturation studies
12) Placental grading
Antepartum Fetal Surveillance
• The goal of antepartum fetal surveillance is to reduce the risk of stillbirth.
• Antepartum fetal surveillance techniques based on assessment of fetal heart
rate (FHR) patterns have been in clinical use for almost four decades and are
used along with real-time ultrasonography and umbilical artery Doppler
velocimetry to evaluate fetal well-being.
Kick Chart
Every kick / roll is 1
movement
Count 10 movements
everyday
Call doctor & come for
CTG / USG assessment
About baby’s movements
An active baby is usually a healthy baby. You
will feel your baby stretch, kick, roll and turn
every day. Some babies are more active than
others. All babies have periods of sleep during
which they are not as active. You will get to
know your baby’s pattern of movements and
when your baby is most active.
You should feel your baby’s movements
throughout the day, each day from 28 weeks of
pregnancy until the baby is born.
When during my pregnancy should I count
my baby’s movements?
Your health care provider may ask you
to count your baby’s movements once
every day.
If you think there is a decrease in your
baby’s movements this is an important sign that
your baby may not be well. Count your baby’s
movements to be sure that you feel at least 6
movements in 2 hours.
Reference:
Society of Obstetricians and Gynaecologists of Canada (2007).
Fetal Health Surveillance : Antepartum and Intrapartum Consensus
Guideline. Journal of Obstetrics and Gynaecology Canada. 29(9).
FETAL MOVEMENT
COUNT CHART
PLEASE BRING THIS CHART WITH YOU EACH
TIME YOU SEE THE DOCTOR/MIDWIFE
IMPORTANT PHONE NUMBERS:
DOCTOR:
MIDWIFE:
HOSPITAL:
DUE DATE:
OTHER INSTRUCTIONS:
For 24-hour nurse advice and health information call
Health Link Alberta:
1-866-408- LINK (5465)– Toll Free
In Calgary call 403-943- LINK (5465)
In Edmonton call 780-408-LINK (5465)
ADDRESS:
NAME:
HS0001-132 (2012/11)
How do I count my baby’s movements?
• Get into a comfortable position – lying on
your side or sitting. Place one or both of your
hands on your abdomen.
• Count each time that you feel your baby
move. If you feel many movements all at
once, count each movement that you feel.
• Write down the date and the time that you
start counting on the fetal movement chart.
• Make a mark on the chart each time your baby
moves.
• Stop counting when you have counted 6
movements.
• Write down the time you stopped counting.
• Do not count for more than 2 hours
What if I don’t feel 6 movements in 2 hours?
Count your baby’s movements once a day. You
should feel 6 or more movements in 2 hours.
If you count fewer than 6 movements in 2 hours
do not wait. Go to the hospital or birthing unit.
Your baby’s heart rate and movements will be
checked using a fetal monitor. This is called a
non-stress test or NST.
If you live too far from a hospital or birthing
unit, immediately contact your health care
provider for advice.
In pregnancies achieved with IVF, does delivery at 39
weeks reduce the risk of adverse perinatal outcomes?
 It is currently unknown whether elective delivery at 39 weeks reduces the risks of maternal morbidity
and improves perinatal outcomes in IVF pregnancies compared with expectant management.
 A systematic review revealed that in asymptomatic uncomplicated singleton gestations, induction of
labor between 39 0/7 and 40 6/7 weeks does not increase the risk of cesarean delivery compared
with expectant management but does not reduce the rates of adverse perinatal outcomes, including
perinatal death, low Apgar score at 5 minutes, or need for NICU admission.53
 In the absence of studies focused specifically on timing of delivery IVF pregnancies, we
recommend shared decision-making between patients and healthcare providers when
considering induction of labor at 39 weeks of gestation (GRADE 1C).54
53.Saccone G, Della Corte L, Maruotti GM, et al. Induction of labor at full-term in pregnant women with uncomplicated singleton pregnancy: A
systematic review and meta-analysis of randomized trials. Acta Obstet Gynecol Scand 2019;98(8):958-966.
54.Lagrew DC, Kane Low L, Brennan R, et al. National Partnership for Maternal Safety: Consensus Bundle on Safe Reduction of Primary Cesarean
Births-Supporting Intended Vaginal Births. J Obstet Gynecol Neonatal Nurs 2018;47(2):214-226.
Multiple pregnancy-Intra Partum Care
Labour management
 IV line
 Delivery in theatre ?
 Twin CTG machine ?
 Two resuscitation trolleys
 Two obstetricians
 Two paediatricians
 Inform NICU
PPH
 IV line
 Blood grouped and saved
 Oxytocin infusion following delivery
Foetal monitoring
 Comparisons of EFM and intermittent auscultation show that
EFM offers no long-term benefits in either low or high-risk
pregnancies (although it may have short-term benefits
especially when oxytocin is used).
 Comparisons of EFM and intermittent auscultation show that
EFM increases the likelihood of cesarean and vaginal
instrumental delivery, infection and cerebral paisy in premature
babies.
LSCS for all ART pregnancies ??
LSCS on demand ?? Mahurat LSCS ??
Perinatal Mortality
 PM rates appear to be increased as much as fourfold
due, at least in part,
 to the obstetric complications discussed above,
 LBW, and
 multiple gestation.
Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro
fertilization: a meta-analysis. Obstet Gynecol 2004; 103:551.
Post partum care
 Puerperal psychosis
 Lactation problems
 Monitoring co-morbidities
 Neonatal care
Maternal Morbidity
• In a retrospective cohort study of over one million deliveries between
2008 and 2012, severe maternal morbidity was nearly twice as likely
in pregnancies conceived with ART compared with non-ART
pregnancies after controlling for maternal age, parity, comorbid
conditions, history of prior cesarean delivery, and year of delivery .
Martin AS, Monsour M, Kissin DM, et al. Trends in Severe Maternal Morbidity After Assisted Reproductive Technology in
the United States, 2008-2012. Obstet Gynecol 2016; 127:59.
Maternal Morbidity
When the same data set was analyzed for antenatal hospitalization,
women with ART pregnancies had an increased risk of antenatal
admission and longer hospitalizations compared with non-ART
pregnancies .
Martin AS, Zhang Y, Crawford S, et al. Antenatal Hospitalizations Among Pregnancies Conceived With and Without Assisted
Reproductive Technology. Obstet Gynecol 2016; 127:941.
Severe maternal morbidity
Severe maternal morbidity – IVF conceived pregnancy may increase
the risk of severe maternal morbidity .
Braat DD, Schutte JM, Bernardus RE, et al. Maternal death related to IVF in the Netherlands 1984-2008. Hum Reprod 2010;
25:1782.
Severe maternal morbidity
 In a cohort study that used propensity score matching and controlled
for multiple factors, including maternal age and multiple gestation,
IVF was associated with a nearly 40 percent increased risk of severe
maternal morbidity compared with spontaneous conception; the
absolute risk of severe maternal morbidity was low (30.8 [IVF] versus
22.2 [spontaneous] per 1000 births) .
 Postpartum hemorrhage, ICU admission, and sepsis were the most
common indicators of severe morbidity.
Dayan N, Joseph KS, Fell DB, et al. Infertility treatment and risk of severe maternal morbidity: a propensity score-matched cohort study. CMAJ
2019; 191:E118.
Mortality
Every procedure does have some inherent risks, including IVF
Risk of maternal mortality among IVF pregnancies is "really
extremely low.
Underlying health issues in women who turn to IVF to get
pregnant may affect their risk profiles.
Counseling
 Risks are rare but they are real and need to be taken into
account when thinking about using IVF to have a baby.
 Many couples may downplay or even ignore the risks due to
their desire to have children.
 Women need to be screened before IVF to make sure they are
appropriate candidates. If women have any underlying diseases
or conditions that could worsen during pregnancy – counseled
accordingly.
Counseling before IVF
 Worsening of pre-existing medical conditions
 Increased risk of chromosomal abnormalities
 risk of multiple pregnancy
 Risks associated with advanced maternal age
 psychosocial impact
Psychological effects
 If fetal reduction done
 Death of one twin
 Frequent ultrasound monitoring
 Anomaly in one fetus
 Risk of Preterm delivery
 Financial burden
 Job worry
Medico legal issues
 Failure to diagnose twins
 Frequency of tests
 Late detection of growth problems
 Wrong estimation of gestational age
Key take aways
Pregnancies achieved by IVF with or without ICSI are at
higher risk for obstetrical and neonatal complications than
spontaneous pregnancies, and close surveillance during
pregnancy should be considered.
Key take aways
 It remains unclear if these increased risks are attributable
to the underlying infertility, characteristics of the infertile
couple, or use of assisted reproductive techniques.
 Multiple gestations remain a significant risk.
Key take aways
Treat each pregnancy as a high-risk pregnancy.
Multidisciplinary approach- ART specialist, high- risk
Obstetrician, Fetal Medicine specialist, Neonatologist
Early screening and prediction of potential problems.
My World of sharing happiness!
Shrikhande Fertility Clinic
Ph- 91 8805577600
shrikhandedrlaxmi@gmail.com
Questions
The Art of Living
Anything that helps
you to become
unconditionally happy
and loving is what is
called spirituality.
H. H. Sri Sri Ravishakar

More Related Content

Similar to IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the leading IVF specialist in India

Multifoetal reduction in Infertility
Multifoetal reduction in InfertilityMultifoetal reduction in Infertility
Multifoetal reduction in InfertilitySujoy Dasgupta
 
Obesity in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. india
Obesity in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. indiaObesity in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. india
Obesity in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. indiaalka mukherjee
 
ANC in cases of post ART
ANC in cases of post ARTANC in cases of post ART
ANC in cases of post ARTkokiladesai
 
Antenatal assessment
Antenatal assessmentAntenatal assessment
Antenatal assessmentKailash Nagar
 
Iugr by dr derar ismerat
Iugr by dr derar ismeratIugr by dr derar ismerat
Iugr by dr derar ismeratDerar Ismerat
 
Update in obstetrics and gynecology 2012
Update in obstetrics and gynecology 2012Update in obstetrics and gynecology 2012
Update in obstetrics and gynecology 2012Dr Zharifhussein
 
F.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCE
F.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCEF.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCE
F.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCENARENDRA MALHOTRA
 
approach to evidence based antenatal Fetal survelliance
approach to evidence based antenatal Fetal survellianceapproach to evidence based antenatal Fetal survelliance
approach to evidence based antenatal Fetal survellianceDr Praman Kushwah
 
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptxDilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptxNiranjan Chavan
 
High-risk approach with screening and assessment
High-risk approach with screening and assessmentHigh-risk approach with screening and assessment
High-risk approach with screening and assessmentAnamika Ramawat
 
Zoltan Veresh - Intrauterine growth retardation
Zoltan Veresh - Intrauterine growth retardationZoltan Veresh - Intrauterine growth retardation
Zoltan Veresh - Intrauterine growth retardationKatalin Cseh
 
ART Multiple gestation Management.ppt
ART Multiple gestation Management.pptART Multiple gestation Management.ppt
ART Multiple gestation Management.pptSriSushmaNagasuri
 
Choriocarcinoma 1
Choriocarcinoma 1Choriocarcinoma 1
Choriocarcinoma 1danilfatah
 
ART Pregnancy - Are they different ?
ART Pregnancy -  Are they different ?ART Pregnancy -  Are they different ?
ART Pregnancy - Are they different ?Vasundhara Hospital
 
Elizabeth GonzalezDr. Alain Llanes RojasAdvanced Primary.docx
Elizabeth GonzalezDr. Alain Llanes RojasAdvanced Primary.docxElizabeth GonzalezDr. Alain Llanes RojasAdvanced Primary.docx
Elizabeth GonzalezDr. Alain Llanes RojasAdvanced Primary.docxchristinemaritza
 

Similar to IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the leading IVF specialist in India (20)

Multifoetal reduction in Infertility
Multifoetal reduction in InfertilityMultifoetal reduction in Infertility
Multifoetal reduction in Infertility
 
IUGR PPT.pptx
IUGR PPT.pptxIUGR PPT.pptx
IUGR PPT.pptx
 
Obesity in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. india
Obesity in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. indiaObesity in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. india
Obesity in pregnancy by dr alka mukherjee dr apurva mukherjee nagpur m.s. india
 
ANC in cases of post ART
ANC in cases of post ARTANC in cases of post ART
ANC in cases of post ART
 
Antenatal assessment
Antenatal assessmentAntenatal assessment
Antenatal assessment
 
Iugr by dr derar ismerat
Iugr by dr derar ismeratIugr by dr derar ismerat
Iugr by dr derar ismerat
 
Update in obstetrics and gynecology 2012
Update in obstetrics and gynecology 2012Update in obstetrics and gynecology 2012
Update in obstetrics and gynecology 2012
 
F.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCE
F.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCEF.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCE
F.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCE
 
approach to evidence based antenatal Fetal survelliance
approach to evidence based antenatal Fetal survellianceapproach to evidence based antenatal Fetal survelliance
approach to evidence based antenatal Fetal survelliance
 
IUGR
IUGRIUGR
IUGR
 
IVF PREGNANCY-IS IT DIFFERENT
IVF PREGNANCY-IS IT DIFFERENTIVF PREGNANCY-IS IT DIFFERENT
IVF PREGNANCY-IS IT DIFFERENT
 
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptxDilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx
 
Twin pregnancy
Twin pregnancyTwin pregnancy
Twin pregnancy
 
High-risk approach with screening and assessment
High-risk approach with screening and assessmentHigh-risk approach with screening and assessment
High-risk approach with screening and assessment
 
Zoltan Veresh - Intrauterine growth retardation
Zoltan Veresh - Intrauterine growth retardationZoltan Veresh - Intrauterine growth retardation
Zoltan Veresh - Intrauterine growth retardation
 
ART Multiple gestation Management.ppt
ART Multiple gestation Management.pptART Multiple gestation Management.ppt
ART Multiple gestation Management.ppt
 
Choriocarcinoma 1
Choriocarcinoma 1Choriocarcinoma 1
Choriocarcinoma 1
 
Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancy
 
ART Pregnancy - Are they different ?
ART Pregnancy -  Are they different ?ART Pregnancy -  Are they different ?
ART Pregnancy - Are they different ?
 
Elizabeth GonzalezDr. Alain Llanes RojasAdvanced Primary.docx
Elizabeth GonzalezDr. Alain Llanes RojasAdvanced Primary.docxElizabeth GonzalezDr. Alain Llanes RojasAdvanced Primary.docx
Elizabeth GonzalezDr. Alain Llanes RojasAdvanced Primary.docx
 

More from Dr.Laxmi Agrawal Shrikhande

Unlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception CareUnlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception CareDr.Laxmi Agrawal Shrikhande
 
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive GuideOptimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive GuideDr.Laxmi Agrawal Shrikhande
 
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...Dr.Laxmi Agrawal Shrikhande
 
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi ShrikhandeOptimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi ShrikhandeDr.Laxmi Agrawal Shrikhande
 
Critical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained InfertilityCritical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained InfertilityDr.Laxmi Agrawal Shrikhande
 
Contraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptxContraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptxDr.Laxmi Agrawal Shrikhande
 
Preview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we goingPreview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we goingDr.Laxmi Agrawal Shrikhande
 

More from Dr.Laxmi Agrawal Shrikhande (20)

Unlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception CareUnlocking Healthier Futures: A Guide to Pre-Conception Care
Unlocking Healthier Futures: A Guide to Pre-Conception Care
 
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive GuideOptimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
Optimizing Fertility: Ovulation Induction in IUI - A Comprehensive Guide
 
Nourishing Your Body: Nutrition at Midlife
Nourishing Your Body: Nutrition at MidlifeNourishing Your Body: Nutrition at Midlife
Nourishing Your Body: Nutrition at Midlife
 
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
Understanding Fever in Pregnancy: What to Do Next | Expert Advice- Dr. Laxmi ...
 
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi ShrikhandeOptimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
Optimizing Nutrition in Midlife: Essential Guidance By Dr Laxmi Shrikhande
 
GDM -what every obstetrician should know.pptx
GDM -what every obstetrician should know.pptxGDM -what every obstetrician should know.pptx
GDM -what every obstetrician should know.pptx
 
Critical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained InfertilityCritical Analysis of ESHRE Guidelines on Unexplained Infertility
Critical Analysis of ESHRE Guidelines on Unexplained Infertility
 
Medical Management of Fibroids
Medical Management of FibroidsMedical Management of Fibroids
Medical Management of Fibroids
 
Medical Management of Fibroids Part 1
Medical Management of Fibroids Part 1Medical Management of Fibroids Part 1
Medical Management of Fibroids Part 1
 
Non Specific Musculoskeletal Pain
Non Specific Musculoskeletal PainNon Specific Musculoskeletal Pain
Non Specific Musculoskeletal Pain
 
Preview of Non Specific Musculoskeletal Pain
Preview of Non Specific Musculoskeletal PainPreview of Non Specific Musculoskeletal Pain
Preview of Non Specific Musculoskeletal Pain
 
Contraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptxContraception where have we been and where are we going.pptx
Contraception where have we been and where are we going.pptx
 
Preview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we goingPreview Contraception where have we been and where are we going
Preview Contraception where have we been and where are we going
 
Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptx
 
Oral health & Pregnancy.pptx
Oral health & Pregnancy.pptxOral health & Pregnancy.pptx
Oral health & Pregnancy.pptx
 
AMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptxAMH & its Clinical Implications.pptx
AMH & its Clinical Implications.pptx
 
Low amh what next
Low amh  what nextLow amh  what next
Low amh what next
 
Combined oral contraceptive pills
Combined oral contraceptive pillsCombined oral contraceptive pills
Combined oral contraceptive pills
 
Update on iron deficiency anemia in pregnacy
Update on iron deficiency anemia in pregnacyUpdate on iron deficiency anemia in pregnacy
Update on iron deficiency anemia in pregnacy
 
Gender based violence in the womb
Gender based violence in the wombGender based violence in the womb
Gender based violence in the womb
 

Recently uploaded

VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...Miss joya
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...astropune
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...Miss joya
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Miss joya
 
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Miss joya
 
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort ServiceCall Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Serviceparulsinha
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Miss joya
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliRewAs ALI
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...CALL GIRLS
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls ServiceMiss joya
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls ServiceMiss joya
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalorenarwatsonia7
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatorenarwatsonia7
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...narwatsonia7
 

Recently uploaded (20)

VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
 
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
 
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort ServiceCall Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
Call Girls Service In Shyam Nagar Whatsapp 8445551418 Independent Escort Service
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas Ali
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
 
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
 
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Baramati ( Pune) Girls Service
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
 

IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the leading IVF specialist in India

  • 1. • Immediate Past Chairperson ICOG –Indian College of OB/GY • National Corresponding Editor-Journal of OB/GY of India JOGI • National Corresponding Secretary-AMWI Association of Medical Women, India • President –ISOPARB Vidarbha Chapter 2019-21 • Chairperson-IMS Education Committee 2021-23 • Chairperson-fertility enhancement Committee- ISOPARB • Member-SAFOG Education Committee • President-Association of Medical Women, Nagpur AMWN 2021-24 • Senior Vice President FOGSI 2012 • President Menopause Society, Nagpur 2016-18 • President Nagpur OB/GY Society 2005-06 Dr. Laxmi Shrikhande MBBS; MD(OB/GY); FICOG; FICMU; FICMCH Medical Director- Shrikhande Fertility Clinic Nagpur, Maharashtra  Nagpur Ratan Award @hands of Union Minister Shri Nitinji Gadkari  Received Bharat excellence Award for women’s health  Received Mehroo Dara Hansotia Best Committee Award for her work as Chairperson HIV/AIDS Committee, FOGSI 2007-2009  Received appreciation letter from Maharashtra Government for her work in the field of SAVE THE GIRL CHILD  Delivered 22 orations and 450 guest lectures  Publications- 42 National & 21 International  Sensitized 2 lakh boys and girls on adolescent health issues Awards Positions
  • 2. IVF Pregnancy - Is it Different ? Dr Laxmi Shrikhande Consultant –Shrikhande Hospital & Research Centre Nagpur
  • 3. ART Pregnancy Assisted reproductive technology (ART) now accounts for 1.6% of all infants and 18.3% of all multiple-birth infants in the United States.  Although most of these pregnancies are uncomplicated, IVF is associated with several adverse maternal and perinatal outcomes.
  • 4. Why are ART pregnancies at higher risk? Maternal age Pre-existing co-morbidities Cause of sub-fertility itself Drugs for ovarian stimulation Previous surgeries IVF procedures
  • 5. Kabhi Khushi Kabhi Gam….. ART can alleviate the burden of infertility on individuals and families, but it can also present challenges - high rates of multiple delivery, preterm delivery, and low birth-weight delivery
  • 6. ART pregnancies – are they different? Reported to be associated with higher risk of complications, which can be- Due to multifetal pregnancies Regardless of multiple gestation
  • 7. Obstetric complications Increased risk of obstetric complication from ART appears to apply to twin gestations as well as singletons. When compared with the non-ART dichorionic twins, the ART neonates had an increased risk of preterm birth (RR 1.13, 95% CI 1.00-1.29), very preterm birth (RR 1.39, 95% CI 1.07-1.82), LBW (RR 1.11, 95% CI 1.00-1.23), and congenital malformations (RR 1.26, 95% CI 1.09-1.46). Luke B, Gopal D, Cabral H, et al. Adverse pregnancy, birth, and infant outcomes in twins: Effects of maternal fertility status and infant gender combinations The Massachusetts Outcomes Study of Assisted Reproductive Technology. Am J Obstet Gynecol 2017.
  • 9. ART Pregnancy- Maternal Risks Miscarriages or Ectopic  15% in women < 35,  25% in women >35 and < 40  35% in women > 42. Multiple pregnancy  Abortion  Gestational hypertension  Placental abruption  Placenta previa.  rate of obstetrical interventions  Induced labour  Elective Caesarean delivery Psychosocial impact
  • 10. ART Pregnancy- Fetal Risks Chromosomal  De novo (mainly sex) chromosomal abnormalities in IVF-ICSI babies for male-factor infertility  Aneuploidy in pregnancies adapted for maternal age and number of fetuses Multiple births  Prematurity  Low birth weight  Neonatal Morbidity & Mortality
  • 11. The best way to protect the mother's health and that of the baby regardless of how the pregnancy occurred is good Antenatal surveillance .
  • 12. Why Antenatal surveillance ?? 1.Triage mothers to High Risk & Low Risk 2.Screen the fetus for Chromosomal errors Structural Defects Growth abnormalities 3.Predict and prevent maternal complications 4.Decide the time and mode of safe delivery
  • 13. Is there a standard protocol? NO
  • 14. Antenatal care Continue Progesterone Support How long? Individualize for every patient profile. Micronized progesterone vaginally is the drug of choice. Continue folic acid supplementation Continue Thyroid medication if she is already on it Continue prescribed medicines by ART consultant
  • 15. Antenatal care Routine Blood Tests Additional blood tests for Monitoring - Look for rising hCG titres Case specific Haemoglobinopathy screening
  • 16. O H S S “Abundance, like want, ruins many”. ~ Romanian Proverb ~
  • 17. Patterns of OHSS Early OHSS generally presents 3–7 days after hCG administration acute effect of ovulatory hCG, and it can occur in patients who do not become pregnant. Late OHSS presenting 12–17 days after hCG. late OHSS is induced by endogenous hCG from the trophoblast of the implanting pregnancy. Wheelan JG 3rd, Vlahos NF. Fertil Steril 2000; 73:883–896.
  • 18. Management of OHSS Principles  Monitoring  Supportive therapy  Maintenance of intravascular volume  Prevention/treatment of complication  Counseling - Signs and symptoms of OHSS
  • 19. Management of OHSS  OUTPATIENT CARE  Limit activity  Weigh daily  Monitor I/O  Daily follow up  Report if symptoms worsen or weight gain > 2lb/day  INPATIENT CARE  Monitor  Vitals every 4 hours  I/O  Daily weight & AG  Hematocrit,TC,DC,  Serum electrolytes, RFT  LFT,PT, APTT on admission repeated if necessary  ICU  Renal faillure,  ARDS,  DIC
  • 20. Mild to Moderate OHSS Increased fluid intake. Frequent physical exams and ultrasounds. Daily weigh-ins and waist measurements to check for drastic changes. Measurements of how much urine you produce each day. Blood tests to monitor for dehydration, electrolyte imbalance and other problems.
  • 21. Who are at risk for OHSS ?
  • 22. Prevention is better than cure Avoid HCG – Cancellation of cycle
  • 23. Which Protocol ? Antagonist Protocol Agonist Trigger Freeze all embryos OHSS free clinic
  • 24. First trimester What would you advise / look for?
  • 25. New shift  Some very important complications that occur later in pregnancy can be predicted in the first trimester itself.  Inverted pyramid helps in dividing cases into high risk & low risk in the first trimester Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagn Ther 2011;29: 183–96.
  • 26. USG @ 6-7 weeks  Exact dating of pregnancy  Ectopic pregnancy/ Heterotopic pregnancy  Missed abortion  Single /Multiple pregnancy  If Multiple-Chorionicity
  • 27. Miscarriage Following ART the risk of miscarriage may seem a bit higher than in spontaneous pregnancies, but  this is thought to be due to earlier pregnancy detection on the one hand,  and to older maternal age on the other
  • 28. Multiple Births  The major complication of IVF is the risk of multiple births  This is directly related to the practice of transferring multiple embryos at embryo transfer.
  • 29. Can Multiple Births be prevented? • Strict limits on the number of embryos that may be transferred have been enacted in some countries (e.g. Britain, Belgium) to reduce the risk of high-order multiples (triplets or more), but are not universally followed or accepted. • Spontaneous splitting of embryos in the womb after transfer can occur, but this is rare and would lead to identical twins.
  • 30. Vanishing Twin  In IVF twins are more often conceived than born. Most vanish in due course of time  Still the true incidence of vanishing twins is difficult to assess.  According to one data it was estimated that ∼30% of these twins will ultimately result in singletons and <10% will end in a complete abortion.
  • 31. Monochorionic twins  More complications because of shared placenta  TTTS  Single twin demise  Mono amnionicity  TRAP  Conjoined twins  When monochorionic twins were compared with dichorionic twin pregnancies , the rate of fetal loss was significantly higher in the former.
  • 32. Management of monochorionic twins  Chorionicity established early  USG surveillance starts at 16 weeks for TTTS & growth discordance  Scan every 2 weeks  If uncomplicated,deliver at 36-37 weeks
  • 33. TTTS  Main feature is growth discordance  If growth discordance >25% , intense surveillance started  NST twice weekly  If non-reactive NST ,biophysical profile done  Doppler studies is done to follow up growth restriction  Interventions when needed
  • 34. Multiple pregnancy AIM of ANC  Prolongation of gestation age, increase fetal weight.  Improve PNM and morbidity.  Decrease incidence of maternal complications. ANC  Consultant-led team  Embryo reduction in higher order multiple gestations  Best after 11 weeks-10% risk of miscarriage  Visits - Every two weeks.  Iron and folic acid to avoid anemia.  Assess cervical length and competency.  Careful watch for complications
  • 35. Multiple pregnancy Maternal Risks-  Hyperemesis gravidarum  Abortion  Hypertensive disease, 4x more common than singletons  Gestational diabetes  Preterm delivery  Anaemia  Hydramnios in 12%, primarily in monozygotic twins  Reflux, abdominal discomfort, back pain, leg swelling,  Bladder symptoms and Hemorrhoids  APH (PP and Abruptio, as larger placental area and PET)  Thromboembolic disease: appropriate prophylaxis and Rx
  • 36. Fetal Risks- • Perinatal Morbidity • Perinatal mortality • Preterm delivery • Low birth weight. Multiple pregnancy
  • 37. Monitoring after Single twin demise / fetal reduction  Baseline coagulation profile for mother  Usually preterm labor starts  Counsel regarding prognosis for second twin  17% risk of neurological damage  Early delivery not warranted as preterm delivery may harm the surviving twin  CS not needed
  • 38.  Embryo reduction in higher order multiple gestations  Best after 11 weeks  10% risk of miscarriage Embryo reduction
  • 39. Embryo reduction  The most common method is to inject potassium chlorideinto the fetus's heart; the heart stops and the fetus dies as a result.  Generally, the fetal material is reabsorbed into the woman's body.  While the procedure generally reduces the over-all risk level for the remaining fetus or fetuses.
  • 40. IVF Multiple Births have Good Outcome  However, despite the risks, some recent evidence suggests that twins conceived by IVF actually have a 40% decreased outcome risk for complications than spontaneous twin conceptions.  Experts believe that this could be due to high level of prenatal monitoring received from the moment of conception.
  • 41. Are congenital anomalies increased in IVF pregnancies?  Meta-analyses demonstrate associations between IVF/ICSI and congenital malformations, although it remains unclear if this association is due to infertility, factors associated with the procedure, or both.30-32 It is also difficult to distinguish the risk associated with IVF alone versus IVF with ICSI.  Therefore, we recommend a detailed obstetrical ultrasound examination (CPT 76811) be performed for pregnancies achieved with IVF and ICSI (GRADE 1B).33 30.Chen L, Yang T, Zheng Z, Yu H, Wang H, Qin J. Birth prevalence of congenital malformations in singleton pregnancies resulting from in vitro fertilization/intracytoplasmic sperm injection worldwide: a systematic review and meta-analysis. Arch Gynecol Obstet 2018;297(5):1115-1130. 31.Hoorsan H, Mirmiran P, Chaichian S, Moradi Y, Hoorsan R, Jesmi F. Congenital Malformations in Infants of Mothers Undergoing Assisted Reproductive Technologies: A Systematic Review and Meta-analysis Study. J Prev Med Public Health 2017;50(6):347-360. 32.Wen J, Jiang J, Ding C, et al. Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis. Fertil Steril 2012;97(6):1331-7.e1-4. 33.AIUM Practice Parameter for the Performance of Detailed Second- and Third-Trimester Diagnostic Obstetric Ultrasound Examinations. J Ultrasound Med 2019;38(12):3093-3100.
  • 42. Are CHD risks increased in IVF pregnancies?  Several studies report higher rates of total congenital heart disease (CHD) in the IVF/ICSI population compared with naturally occurring pregnancies, while other studies report that the incidence of CHD in IVF pregnancies without other risk factors is not significantly different from baseline population rates.34 The cost-effectiveness of routine screening for CHD in pregnancies following IVF has also been questioned.35,36  We suggest fetal echocardiography be offered to patients with pregnancies achieved with IVF and ICSI (GRADE 2C).37 34.Giorgione V, Parazzini F, Fesslova V, et al. Congenital heart defects in IVF/ICSI pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018;51(1):33-42. 35.Bjorkman KR, Bjorkman SH, Ferdman DJ, Sfakianaki AK, Copel JA, Bahtiyar MO. Utility of routine screening fetal echocardiogram in pregnancies conceived by in vitro fertilization. Fertility and Sterility 2021. 36.Chung EH, Lim SL, Havrilesky LJ, Steiner AZ, Dotters-Katz SK. Cost-effectiveness of prenatal screening methods for congenital heart defects in pregnancies conceived by in-vitro fertilization. Ultrasound Obstet Gynecol 2021;57(6):979-986. 37.AIUM Practice Parameter for the Performance of Fetal Echocardiography. J Ultrasound Med 2020;39(1):E5-e16.
  • 43. Antenatal care Hyperemesis-challenge with so many medications Discuss options for prenatal screening for congenital structural abnormalities Biochemical Sonographic screening
  • 44. Antenatal care-11-13 weeks Self egg versus donor egg cycle  Screening for the baby:  Combined test –Double Marker  USG – NT & Soft tissue Markers  assessing normal fetal growth  Vanishing twins  Need for fetal reduction  Cervical length  P/S exam  CVB/ NIPT
  • 45. Prenatal diagnosis  Nuchal translucency measurement with maternal age is the best method for aneuploidy screening  Advantage: fetus specific  Structural anomaly scan for NTDs  Combine NT scan with Uterine artery Doppler,  Tricuspid flow and DV -95-97%
  • 46. Screening for Trisomy 21 at 11- 14 weeks for India 2-stage (contingency) screening proposed RISK ESTIMATE BY ONLY USG N.T. AND OTHER MARKERS Fetal NT Nasal bone and ductus venosus tricuspid regurgitation at 12 wks Very high risk Very low risk CVS Reassure Borderline risk Further screening Free B hCG PAPP-A THIS WILL SAVE TIME MONEY OPTIMUM USE OF OUR SKILL DOUBLE MARKER TEST Scan 20w NIPT
  • 47. Antenatal care  Screening for the pregnant woman:  Gestational diabetes  Pre-eclampsia and preterm labour  Placenta Previa  Asymptomatic bacteriuria  Chlamydia.
  • 48. Cervical length screening routine to prevent preterm labour and for guideline for cx stitch Asymptomatic singleton pregnancy a tvs cl <25 mm in second trimester Screen at 11-13 weeks and then at 22-24 weeks Recent evidence says cx stitch does not help and progesterone may be the only treatment option here. Routine mcdonald stitch practise should be individualised
  • 49. ANC care @ 18-20 weeks Self egg versus donor egg cycle Quadruple Marker Anomaly scan Cervical length P/S exam NIPT/Amniocentesis Fetal ECHO @ 22 weeks
  • 50. PIH  A cohort study of over 5 Lakh women was done to determine the risk of preeclampsia in women undergoing ART, including IVF, compared with women who had a natural conception.  After adjusting for maternal age, interbirth interval, and presence of new partner, women undergoing ART had a small increase in odds of preeclampsia in their second and third pregnancies compared with women who did not require ART (OR 1.3 for second pregnancy and 1.8 for third pregnancy) . Tandberg A, Klungsøyr K, Romundstad LB, Skjærven R. Pre-eclampsia and assisted reproductive technologies: consequences of advanced maternal age, interbirth intervals, new partner and smoking habits. BJOG 2015; 122:915.
  • 51. PIH in OD cycle • In a meta-analysis of 19 studies (mainly retrospective) that compared the risk of preeclampsia and gestational hypertension in pregnancies conceived via oocyte donation (OD), other ART, and natural conception, pregnancies achieved with OD had more than double the risk of preeclampsia when compared with other methods of ART and a more than fourfold increased risk compared with natural conception (OR 2.54, 95% CI 1.98-3.24 and OR 4.34, 95% CI 3.10-6.06, respectively) . Masoudian P, Nasr A, de Nanassy J, et al. Oocyte donation pregnancies and the risk of preeclampsia or gestational hypertension: a systematic review and metaanalysis. Am J Obstet Gynecol 2016; 214:328.
  • 52. In pregnancies achieved with IVF,does low-dose aspirin prophylaxis reduce the risk of fetal & placental complications?  IVF and underlying infertility are associated with adverse perinatal outcomes, including hypertensive disorders of pregnancy.47 The United States Preventative Services Task Force states IVF is a moderate risk factor for preeclampsia and recommends low-dose aspirin if an additional moderate risk factor is found.48  We do not recommend low-dose aspirin in patients with an IVF pregnancy as the sole indication for preeclampsia prophylaxis; however, if one or more additional risk factors are present, low-dose aspirin is recommended (GRADE 1B). 47.Tandberg A, Klungsoyr K, Romundstad LB, Skjaerven R. Pre-eclampsia and assisted reproductive technologies: consequences of advanced maternal age, interbirth intervals, new partner and smoking habits. BJOG 2015;122(7):915-22 48.Davidson KW, Barry MJ, Mangione CM, et al. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement. Jama 2021;326(12):1186-1191.
  • 53. PIH/PTB/LSCS in OD Cycle  A different meta-analysis of 11 studies that compared oocyte donation (OD) pregnancies with pregnancies resulting from autologous oocyte IVF or ICSI reported that women with OD pregnancies had a nearly fourfold increased risk of developing preeclampsia or pregnancy-induced hypertension compared with autologous IVF/ICSI pregnancies (OR 3.92, 95% CI 2.62-5.16).  The increased risk was independent of maternal age.  In secondary analysis, OD pregnancies were also associated with an increased risk of preterm delivery and cesarean delivery. Jeve YB, Potdar N, Opoku A, Khare M. Donor oocyte conception and pregnancy complications: a systematic review and meta-analysis. BJOG 2016; 123:1471.
  • 54.
  • 55. Is the prevalence of spontaneous preterm birth higher in IVF pregnancies?  A meta-analysis of singleton pregnancies demonstrated that IVF is associated with higher odds of preterm delivery, low birthweight, and very low birthweight compared with naturally occurring pregnancies.40  Preterm birth has been recognized for several decades as the primary independent cause of increased rates of several adverse neonatal outcomes, including neonatal encephalopathy and perinatal mortality, in IVF pregnancies.  Such risks are more than double in the presence of IVF twin gestations. Subfertility is also a major risk factor for prematurity.41 Although there may be an increased risk for spontaneous preterm birth with IVF pregnancies, the utility of serial cervical length measurement to screen for preterm birth risk is unknown when the sole indication is IVF.  Although visualization of the cervix at the 18 0/7 to 22 6/7 weeks of gestation anatomy assessment with either a transabdominal or endovaginal approach is recommended, we do not recommend serial cervical length assessment as a routine practice for IVF pregnancies (GRADE 1C).42,43  In addition, progesterone supplementation initiated for IVF cycles is not indicated after 12 weeks of gestation if it was solely initiated for IVF purposes without any other indication. Discontinuation of progesterone supplementation initiated for the sole purpose of IVF is recommended by 12 weeks. 40.Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004;103(3):551-63. 41.Pinborg A, Wennerholm UB, Romundstad LB, et al. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta- analysis. Hum Reprod Update 2013;19(2):87-104. 42.Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234. Obstet Gynecol 2021;138(2):e65-e90. 43.McIntosh J, Feltovich H, Berghella V, Manuck T. The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention. Am J Obstet Gynecol 2016;215(3):B2-7.
  • 56. Is the prevalence of fetal growth restriction higher in IVF pregnancies?  An increased risk of small for gestational age (SGA) infants is documented for singleton IVF pregnancies. Meta-analyses have described a higher risk of SGA babies in IVF/ICSI pregnancies from fresh cycles compared with frozen cycles.41,44-46  The optimal gestational ages for fetal growth scans and their frequency in the presence of additional risk factors (eg, placental implantation anomalies or maternal age >40 years) are presently unknown.  We suggest an assessment of fetal growth in the third trimester for IVF pregnancies; however, serial growth ultrasounds are not recommended for the sole indication of IVF (GRADE 2B). 44.Maheshwari A, Pandey S, Shetty A, Hamilton M, Bhattacharya S. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril 2012;98(2):368-77.e1-9. 45.Sha T, Yin X, Cheng W, Massey IY. Pregnancy-related complications and perinatal outcomes resulting from transfer of cryopreserved versus fresh embryos in vitro fertilization: a meta-analysis. Fertil Steril 2018;109(2):330-342.e9. 46.Wennerholm UB, Henningsen AK, Romundstad LB, et al. Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic cohort study from the CoNARTaS group. Hum Reprod 2013;28(9):2545-53.
  • 57. Third trimester  Close monitoring for fetal growth  Close monitoring for preterm labour  Pay special attention to Placenta-praevia, adherent Sun LM, Walker MC, Cao HL, et al. Assisted reproductive technology and placenta-mediated adverse pregnancy outcomes. Obstet Gynecol 2009; 114:818. Romundstad LB, Romundstad PR, Sunde A, et al. Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother. Hum Reprod 2006; 21:2353.
  • 58. Are placental anomalies increased in IVF pregnancies?  IVF pregnancies are associated with higher risks for abnormal placental shape (bilobed placenta, accessory placental lobes), placenta previa, marginal or velamentous cord insertion, and placenta accreta spectrum compared with naturally occurring pregnancies.  All of the above manifestations of placental implantation disorders appear related and can occur together.  Therefore, we recommend a careful examination of the placental location, placental shape, and cord insertion site be performed at the time of the detailed fetal anatomy ultrasound, including evaluation for vasa previa (GRADE 1B).  Targeted screening via transvaginal sonogram should be considered in all IVF pregnancies with velamentous cord insertion, succenturiate or bilobed placentas, or resolved placenta previa to rule out vasa previa.38,39 Due to the ongoing risk of vasa previa in the setting of resolved placenta previa, reassessment for vasa previa is warranted when reassessing placental location at 32 weeks of gestation. 38.Sinkey RG, Odibo AO, Dashe JS. #37: Diagnosis and management of vasa previa. Am J Obstet Gynecol 2015;213(5):615-9. 39.Sullivan EA, Javid N, Duncombe G, et al. Vasa Previa Diagnosis, Clinical Practice, and Outcomes in Australia. Obstet Gynecol 2017;130(3):591-598.
  • 59. Placenta Praevia • In a meta-analysis of 15 cohort studies comparing ART-conceived with naturally conceived dichorionic twins, women with ART dichorionic twins had nearly three times the risk of placenta previa as women with naturally conceived dichorionic twins (RR 2.99, 95% CI 1.5-5.9) . Qin JB, Wang H, Sheng X, et al. Assisted reproductive technology and risk of adverse obstetric outcomes in dichorionic twin pregnancies: a systematic review and meta-analysis. Fertil Steril 2016; 105:1180.
  • 60. Antenatal corticosteroids • A single course of corticosteroids is recommended for pregnant women between 24 0/7 weeks and 33 6/7 weeks of gestation who are at risk of preterm delivery within 7 days, including for those with ruptured membranes and multiple gestations.
  • 61. Antenatal corticosteroids • It also may be considered for pregnant women starting at 23 0/7 weeks of gestation who are at risk of preterm delivery within 7 days, based on a family’s decision regarding resuscitation, irrespective of membrane rupture status and regardless of fetal number.
  • 62. Antenatal corticosteroids • Administration of betamethasone may be considered in pregnant women between 34 0/7 weeks and 36 6/7 weeks of gestation who are at risk of preterm birth within 7 days, and who have not received a previous course of antenatal corticosteroids.
  • 63. Antenatal corticosteroids 24-34 weeks [Grade A recommendation] More effective when delivered after 24 hours and upto 7 days after 2nd dose [Grade A] Repeated doses not needed Consider rescue dose if initial dose before 26 weeks
  • 64. Fetal Care  Combined Screening,Fetal ECHO, LBW, IUGR…  NT,soft tissue markers,double marker,  dedicated anomaly scan, quadruple marker,  3 D USG,  serial USG,  Doppler…  Fetal Kick Count
  • 65. Is the prevalence of stillbirth increased in IVF pregnancies?  Pregnancies achieved with IVF have a two to three-fold increased risk of stillbirth even after controlling for maternal age, parity, and multifetal gestations.40,49-51  Given the increased risk of stillbirth, we suggest weekly antenatal fetal surveillance beginning by 36 0/7 weeks of gestation for pregnancies achieved with IVF (GRADE 2C).52 49.Bay B, Boie S, Kesmodel US. Risk of stillbirth in low-risk singleton term pregnancies following fertility treatment: a national cohort study. BJOG 2019;126(2):253-260. 50.Marino JL, Moore VM, Willson KJ, et al. Perinatal outcomes by mode of assisted conception and sub-fertility in an Australian data linkage cohort. PLoS One 2014;9(1):e80398. 51.Wisborg K, Ingerslev HJ, Henriksen TB. IVF and stillbirth: a prospective follow-up study. Hum Reprod 2010;25(5):1312-6. 52.Indications for Outpatient Antenatal Fetal Surveillance: ACOG Committee Opinion, Number 828. Obstet Gynecol 2021;137(6):e177-e197.
  • 66. Stillbirth A national cohort study from Denmark of low-risk ART pregnancies reported stillbirth rates of 0.1 percent following IVF and 0.3 percent after ICSI .  For low-risk patients, it is not known if the increased stillbirth risk is related to the treatment or the underlying subfertility. Bay B, Boie S, Kesmodel US. Risk of stillbirth in low-risk singleton term pregnancies following fertility treatment: a national cohort study. BJOG 2019; 126:253.
  • 67. The Various Methods of Antepartum Fetal Surveillance 1) Clinical assessment by uterine growth 2) Fetal movement count by the mother 3) Ultrasound for fetal growth 4) Non stress test and cardiotocography 5) Vibroacoustic stimulation test 6) Contraction stress test 7) Nipple stimulation test 8) Biophysical profile 9) Modified biophysical profile 10) Doppler studies 11) Fetal lung maturation studies 12) Placental grading
  • 68. Antepartum Fetal Surveillance • The goal of antepartum fetal surveillance is to reduce the risk of stillbirth. • Antepartum fetal surveillance techniques based on assessment of fetal heart rate (FHR) patterns have been in clinical use for almost four decades and are used along with real-time ultrasonography and umbilical artery Doppler velocimetry to evaluate fetal well-being.
  • 69. Kick Chart Every kick / roll is 1 movement Count 10 movements everyday Call doctor & come for CTG / USG assessment
  • 70. About baby’s movements An active baby is usually a healthy baby. You will feel your baby stretch, kick, roll and turn every day. Some babies are more active than others. All babies have periods of sleep during which they are not as active. You will get to know your baby’s pattern of movements and when your baby is most active. You should feel your baby’s movements throughout the day, each day from 28 weeks of pregnancy until the baby is born. When during my pregnancy should I count my baby’s movements? Your health care provider may ask you to count your baby’s movements once every day. If you think there is a decrease in your baby’s movements this is an important sign that your baby may not be well. Count your baby’s movements to be sure that you feel at least 6 movements in 2 hours. Reference: Society of Obstetricians and Gynaecologists of Canada (2007). Fetal Health Surveillance : Antepartum and Intrapartum Consensus Guideline. Journal of Obstetrics and Gynaecology Canada. 29(9). FETAL MOVEMENT COUNT CHART PLEASE BRING THIS CHART WITH YOU EACH TIME YOU SEE THE DOCTOR/MIDWIFE IMPORTANT PHONE NUMBERS: DOCTOR: MIDWIFE: HOSPITAL: DUE DATE: OTHER INSTRUCTIONS: For 24-hour nurse advice and health information call Health Link Alberta: 1-866-408- LINK (5465)– Toll Free In Calgary call 403-943- LINK (5465) In Edmonton call 780-408-LINK (5465) ADDRESS: NAME: HS0001-132 (2012/11) How do I count my baby’s movements? • Get into a comfortable position – lying on your side or sitting. Place one or both of your hands on your abdomen. • Count each time that you feel your baby move. If you feel many movements all at once, count each movement that you feel. • Write down the date and the time that you start counting on the fetal movement chart. • Make a mark on the chart each time your baby moves. • Stop counting when you have counted 6 movements. • Write down the time you stopped counting. • Do not count for more than 2 hours What if I don’t feel 6 movements in 2 hours? Count your baby’s movements once a day. You should feel 6 or more movements in 2 hours. If you count fewer than 6 movements in 2 hours do not wait. Go to the hospital or birthing unit. Your baby’s heart rate and movements will be checked using a fetal monitor. This is called a non-stress test or NST. If you live too far from a hospital or birthing unit, immediately contact your health care provider for advice.
  • 71. In pregnancies achieved with IVF, does delivery at 39 weeks reduce the risk of adverse perinatal outcomes?  It is currently unknown whether elective delivery at 39 weeks reduces the risks of maternal morbidity and improves perinatal outcomes in IVF pregnancies compared with expectant management.  A systematic review revealed that in asymptomatic uncomplicated singleton gestations, induction of labor between 39 0/7 and 40 6/7 weeks does not increase the risk of cesarean delivery compared with expectant management but does not reduce the rates of adverse perinatal outcomes, including perinatal death, low Apgar score at 5 minutes, or need for NICU admission.53  In the absence of studies focused specifically on timing of delivery IVF pregnancies, we recommend shared decision-making between patients and healthcare providers when considering induction of labor at 39 weeks of gestation (GRADE 1C).54 53.Saccone G, Della Corte L, Maruotti GM, et al. Induction of labor at full-term in pregnant women with uncomplicated singleton pregnancy: A systematic review and meta-analysis of randomized trials. Acta Obstet Gynecol Scand 2019;98(8):958-966. 54.Lagrew DC, Kane Low L, Brennan R, et al. National Partnership for Maternal Safety: Consensus Bundle on Safe Reduction of Primary Cesarean Births-Supporting Intended Vaginal Births. J Obstet Gynecol Neonatal Nurs 2018;47(2):214-226.
  • 72. Multiple pregnancy-Intra Partum Care Labour management  IV line  Delivery in theatre ?  Twin CTG machine ?  Two resuscitation trolleys  Two obstetricians  Two paediatricians  Inform NICU PPH  IV line  Blood grouped and saved  Oxytocin infusion following delivery
  • 73. Foetal monitoring  Comparisons of EFM and intermittent auscultation show that EFM offers no long-term benefits in either low or high-risk pregnancies (although it may have short-term benefits especially when oxytocin is used).  Comparisons of EFM and intermittent auscultation show that EFM increases the likelihood of cesarean and vaginal instrumental delivery, infection and cerebral paisy in premature babies.
  • 74. LSCS for all ART pregnancies ??
  • 75. LSCS on demand ?? Mahurat LSCS ??
  • 76. Perinatal Mortality  PM rates appear to be increased as much as fourfold due, at least in part,  to the obstetric complications discussed above,  LBW, and  multiple gestation. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004; 103:551.
  • 77. Post partum care  Puerperal psychosis  Lactation problems  Monitoring co-morbidities  Neonatal care
  • 78. Maternal Morbidity • In a retrospective cohort study of over one million deliveries between 2008 and 2012, severe maternal morbidity was nearly twice as likely in pregnancies conceived with ART compared with non-ART pregnancies after controlling for maternal age, parity, comorbid conditions, history of prior cesarean delivery, and year of delivery . Martin AS, Monsour M, Kissin DM, et al. Trends in Severe Maternal Morbidity After Assisted Reproductive Technology in the United States, 2008-2012. Obstet Gynecol 2016; 127:59.
  • 79. Maternal Morbidity When the same data set was analyzed for antenatal hospitalization, women with ART pregnancies had an increased risk of antenatal admission and longer hospitalizations compared with non-ART pregnancies . Martin AS, Zhang Y, Crawford S, et al. Antenatal Hospitalizations Among Pregnancies Conceived With and Without Assisted Reproductive Technology. Obstet Gynecol 2016; 127:941.
  • 80. Severe maternal morbidity Severe maternal morbidity – IVF conceived pregnancy may increase the risk of severe maternal morbidity . Braat DD, Schutte JM, Bernardus RE, et al. Maternal death related to IVF in the Netherlands 1984-2008. Hum Reprod 2010; 25:1782.
  • 81. Severe maternal morbidity  In a cohort study that used propensity score matching and controlled for multiple factors, including maternal age and multiple gestation, IVF was associated with a nearly 40 percent increased risk of severe maternal morbidity compared with spontaneous conception; the absolute risk of severe maternal morbidity was low (30.8 [IVF] versus 22.2 [spontaneous] per 1000 births) .  Postpartum hemorrhage, ICU admission, and sepsis were the most common indicators of severe morbidity. Dayan N, Joseph KS, Fell DB, et al. Infertility treatment and risk of severe maternal morbidity: a propensity score-matched cohort study. CMAJ 2019; 191:E118.
  • 82. Mortality Every procedure does have some inherent risks, including IVF Risk of maternal mortality among IVF pregnancies is "really extremely low. Underlying health issues in women who turn to IVF to get pregnant may affect their risk profiles.
  • 83. Counseling  Risks are rare but they are real and need to be taken into account when thinking about using IVF to have a baby.  Many couples may downplay or even ignore the risks due to their desire to have children.  Women need to be screened before IVF to make sure they are appropriate candidates. If women have any underlying diseases or conditions that could worsen during pregnancy – counseled accordingly.
  • 84. Counseling before IVF  Worsening of pre-existing medical conditions  Increased risk of chromosomal abnormalities  risk of multiple pregnancy  Risks associated with advanced maternal age  psychosocial impact
  • 85. Psychological effects  If fetal reduction done  Death of one twin  Frequent ultrasound monitoring  Anomaly in one fetus  Risk of Preterm delivery  Financial burden  Job worry
  • 86. Medico legal issues  Failure to diagnose twins  Frequency of tests  Late detection of growth problems  Wrong estimation of gestational age
  • 87. Key take aways Pregnancies achieved by IVF with or without ICSI are at higher risk for obstetrical and neonatal complications than spontaneous pregnancies, and close surveillance during pregnancy should be considered.
  • 88. Key take aways  It remains unclear if these increased risks are attributable to the underlying infertility, characteristics of the infertile couple, or use of assisted reproductive techniques.  Multiple gestations remain a significant risk.
  • 89. Key take aways Treat each pregnancy as a high-risk pregnancy. Multidisciplinary approach- ART specialist, high- risk Obstetrician, Fetal Medicine specialist, Neonatologist Early screening and prediction of potential problems.
  • 90. My World of sharing happiness! Shrikhande Fertility Clinic Ph- 91 8805577600 shrikhandedrlaxmi@gmail.com
  • 92. The Art of Living Anything that helps you to become unconditionally happy and loving is what is called spirituality. H. H. Sri Sri Ravishakar